NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/08/2026
Back to search
Official data from USPTO
ARMATA PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ARMATA PHARMACEUTICALS
ST13
US500000088976598Class
40, 42
Filing
88976598
Registration
6015381
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
06/30/2026
Trademark type
Word
Nice classes
40, 42
Filing date
01/29/2019
Registration date
03/17/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/08/2026
Last transaction
06/30/2026
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/09/2019
First use in commerce
05/09/2019
Drawing code
4
Owner type
03
Owner location
MARINA DEL REY, CA, US
Examiner
SIMCOX, KYLE DUNCAN
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ARMATA PHARMACEUTICALS, INC.
C3J Therapeutics, Inc.
Representatives
Karen Won Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacturing of medicines and pharmaceuticals
Class 42
Research and development in the fields of medicine and pharmaceuticalsexcluding the field of medical imaging
Publications
History of USPTO decisions and trademark events.
43 publications found
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/08/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/08/2026
E815
TEAS SECTION 8 & 15 RECEIVED
03/13/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/17/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/11/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/10/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/31/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/31/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/16/2020
DPCC
DIVISIONAL PROCESSING COMPLETE
01/16/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/15/2020
IUAF
USE AMENDMENT FILED
01/09/2020
EISU
TEAS STATEMENT OF USE RECEIVED
01/09/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/24/2019
CORV
REVIEW OF CORRESPONDENCE COMPLETE
11/22/2019
APET
ASSIGNED TO PETITION STAFF
11/19/2019
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
11/18/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/29/2019
PUBO
PUBLISHED FOR OPPOSITION
10/29/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/20/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/27/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/26/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/26/2019
DRRR
DIVISIONAL REQUEST RECEIVED
07/22/2019
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
07/22/2019
GAUN
NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
07/08/2019
GAUD
NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
07/08/2019
NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
07/08/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2019
ALIE
ASSIGNED TO LIE
06/11/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
06/05/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/18/2019
GNRT
NON-FINAL ACTION E-MAILED
04/18/2019
CNRT
NON-FINAL ACTION WRITTEN
04/18/2019
DOCK
ASSIGNED TO EXAMINER
04/10/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/27/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/21/2019
NWAP
NEW APPLICATION ENTERED
02/01/2019
Continuous trademark protection
Get notified about every new filing that threatens ARMATA PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.